Showing results (21-30 of 234) with videos related to
Sort By:
Pageof 24
Urology|April 3, 2003
Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostateMack Roach, Vivian Weinberg, Patrick W McLaughlin, et al.International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Family history of prostate cancer and relapse after definitive external beam radiation therapyMichael E Ray, Rodney L Dunn, Kathleen A Cooney, et al.International Journal of Radiation Oncology, Biology, Physics|January 19, 2023
Recent Trends in Medicare Payments for Outpatient Cancer Care at the End of LifeConstantine A Mantz, Catheryn M Yashar, Gopal K Bajaj, et al.International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningiomaSamir Narayan, Wayne T Cornblath, Howard M Sandler, et al.The Journal of Urology|September 6, 2006
E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomesMichael E Ray, Rohit Mehra, Howard M Sandler, et al.International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapyZvi Symon, Kent A Griffith, P William McLaughlin, et al.Cancer|October 20, 2011
Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancerNirav S Kapadia, Karin Olson, Howard M Sandler, et al.Cancer|April 4, 2003
Overview of bladder cancer trials in the Radiation Therapy Oncology GroupWilliam U Shipley, Donald S Kaufman, William J Tester, et al.Urology|May 12, 2004
Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancerBrent K Hollenbeck, John T Wei, Martin G Sanda, et al.Seminars in Radiation Oncology|January 22, 2005
Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiencesWilliam U Shipley, Anthony L Zietman, Donald S Kaufman, et al.Pageof 24